NCT05412680 (TOETVA) is a NA clinical trial of TOETVA in Thyroid Diseases, sponsored by Fábio de Aquino Capelli.

Who is sponsoring NCT05412680?

NCT05412680 is sponsored by Fábio de Aquino Capelli.

What drugs are being tested in NCT05412680?

Interventions in NCT05412680: TOETVA, conventional thyroidectomy.

What condition does NCT05412680 study?

NCT05412680 studies Thyroid Diseases, Thyroid Cancer.

Is NCT05412680 still recruiting?

NCT05412680 is currently status unknown. Last updated 14 May 2024.

Last reviewed 2024-05-14 · How we verify

NCT05412680: TOETVA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)

Status unknown NA Last updated 14 May 2024

What this trial tests

NA trial testing TOETVA in Thyroid Diseases in 60 participants. Status unknown.

Timeline

25 May 2022

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Fábio de Aquino Capelli
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	25 May 2022
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Brazil

Drugs / interventions tested

TOETVA
conventional thyroidectomy

Conditions studied

Thyroid Diseases — all drugs for Thyroid Diseases →
Thyroid Cancer — all drugs for Thyroid Cancer →

Sponsor

Fábio de Aquino Capelli

Who can join

Adults 18 to 70, any sex, with Thyroid Diseases or Thyroid Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective study carried out with ICESP (instituto do Câncer do Estado de São Paulo) patients with thyroid disease with surgical indication

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of TOETVA

Trials testing the same drug.

NCT05396703 — TOETVA Feasibility and Complications - Single Center First Experience · completed

Other recruiting trials for Thyroid Diseases

Currently open trials in the same condition.

NCT07462195 — Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery · Phase 4 · recruiting
NCT07382973 — Safety and Efficacy of NTP in Thyroid Surgery: Pilot Study on Morbidity Prevention and Adjuvant Oncological Control · NA · recruiting
NCT07043166 — Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens · recruiting
NCT06752239 — Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC · Phase 3 · recruiting
NCT06730321 — Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05412680 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fábio de Aquino Capelli
Last refreshed: 14 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05412680.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing